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ABSTRACT
Antibody library technology represents a powerful
tool for the discovery and design of antibodies with
highaffinityandspecificityfortheirtargets.Toextend
the technique to the expression and selection of anti-
body libraries in an eukaryotic environment, we pro-
vide here a proof of concept that retroviruses can be
engineered for the display and selection of variable
single-chainfragment(scFv)libraries.Aretrovirallib-
rary displaying the repertoire obtained after a single
round of selection of a human synthetic scFv phage
display library on laminin was generated. For selec-
tion, antigen-bound virus was efficiently recovered
by an overlay with cells permissive for infection. This
approach allowed more than 10
3-fold enrichment of
antigenbindersinasingleselectioncycle.Afterthree
selectioncycles,severalscFvswererecoveredshow-
ing similar laminin-binding activities but improved
expression levels in mammalian cells as compared
with a laminin-specific scFv selected by the conven-
tional phage display approach. Thus, translational
problemsthatoccurwhenphage-selected antibodies
have to be transferred onto mammalian expression
systems to exert their therapeutic potential can be
avoided by the use of retroviral display libraries.
INTRODUCTION
Thedisplayofforeign polypeptidesandproteinson thesurface
of viruses or cells provides an important tool for the engin-
eering of biomolecules and the analysis of their interactions
withbindingpartners(1,2).Displaytechnologyhasmadegreat
progress over the last 10 years and covers applications ranging
from basic research to diagnosis and therapy. One of the most
successfully and extensively used display technology is the
isolation of recombinant antibodies [variable single-chain
fragments (scFvs)] from large combinatorial libraries dis-
played on the pIII coat protein of the ﬁlamentous bacterio-
phage (3). Such antibodies that recognize, for example,
cell-surface markers, growth factors or extracellular matrix
proteins were also proved to be effective for novel therapeutic
strategiesincluding cancer treatment.Recently,forexample,it
has been shown that an anti-laminin antibody (L36), isolated
from a large synthetic scFv display library with a repertoire
of >5 · 10
10, was able to inhibit blood vessel formation and to
prevent tumour growth (4,5).
Besidesphage, otherdisplay platforms have been developed
including yeast and bacteria cells, and also retroviruses (6–9).
The envelope spike glycoprotein (Env) of the murine leuk-
aemia virus (MLV) proved to be especially amenable to
N-terminal extensions by foreign polypeptides (10). The Env
protein is a homotrimeric complex (11,12) with each subunit
of the trimer consisting of the SU (surface) and the TM com-
ponent, which anchors the complex in the viral membrane
(13). The SU glycoprotein mediates the attachment of the
virion to its cellular receptor (14). Receptor choice determines
the host range of MLV. Ecotropic viruses use the murine
Rec-1 protein as receptor. As the humanallele does not encode
a functional receptor the tropism of these viruses is restricted
to murine cells.
Growth factors, cytokines, extracellular parts of transmem-
brane proteins and also scFvs have been displayed on MLV by
extending the N-terminus of the SU protein (15). These modi-
ﬁcations usually result in the binding of the virus particles to
the corresponding cell surface receptor or antigen. However,
efﬁcient functional cell entry via the targeted cell surface
molecule resulting in an infectious cycle does not occur
(15,16). The potential of retroviral display for the generation
and screening of eukaryotic expression libraries has so far
been demonstrated for small peptides of  7–10 amino
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doi:10.1093/nar/gni033acids. These retroviral peptide display libraries were success-
fully selected for the identiﬁcation of protease substrates
(17,18) or antibody epitopes (19). In this study, we present
the ﬁrst retroviral scFv display library, which allowed as a
proof of concept the selection of functional human anti-
laminin antibodies.
MATERIALS AND METHODS
Generation of the plasmids
All the plasmids encoding scFv viruses in this study were
derived from pE-Mo (18). First, the ecotropic env gene in
pE-Mo was exchanged with the ecotropic env gene harbouring
N-terminally a factor Xa cleavage site from the plasmid
pN-XMo (kindly provided by M. Chadwick) via the NotI/ClaI
restriction sites to give pE-XMo, in which a factor Xa cleav-
age site is encoded between the NotI site and the ﬁrst codon
of the SU protein. To construct the viral scFv library as well as
the 7A5-XMo and L36-XMo viruses, the scFv-coding regions
were ampliﬁed from the Grifﬁn.1 library (5) or pHEN-2-L36
(20) or pHEN2-7A5 (21) by PCR using primer LMB3 (50-
CACAGGAAACAGCTATGAC-30) and pHEN-Seq (50-CT-
ATGCGGCCCCATTC-30). The PCR fragments were SﬁI/
NotI-digested and ligated into the SﬁI/NotI-digested pE-
XMo. RT–PCR fragments encoding the selected scFvs were
cloned into the pGEM-T-Easy vector (Promega). To recon-
stitute the viruses L6-, L9- and L28-XMo, the scFv-coding
sequences were subcloned from the corresponding pGEM-T-
Easy plasmids into pE-XMo via SﬁI/NotI. To generate the
scFv expression plasmids, the L6 and L28 scFv-coding
regions were ampliﬁed by PCR from the plasmids pscFv-
L6-XMo and pscFv-L28-XMo using primer pairs L6XMoC
(50-CCATCGATGCAGGTGCAGCTGGTGC-30)andscFvXN
(50-CCTCGATTGCGGCCGCACCTAGGA-30) or L28XMoC
(50-CCATCGATGCAGGTGCAGCTGTTGC-30)andscFvXN.
The ClaI/NotI-digested PCR fragments were ligated into the
ClaI/NotI-digested backbone of the plasmid pCR3.1-L36
(22), to obtain the plasmids pCR3.1-L6 and pCR3.1-L28.
The identity of the sequence was veriﬁed using the primer
BGHReverse (50-TAGAAGGCACAGTCGAGG-30).
Ligation and cloning conditions were basically the same as
described previously with the exception that ElectroTen-Blue
bacterial cells (Stratagene) were used in 1 cm cuvettes at 1.7
kV, 200 V and 25 mF (18). Electroporated bacteria were
plated, pooled and subsequently grown in liquid medium
for the puriﬁcation of plasmid DNA. Restriction and sequence
analyses of45randomlypickedclonesconﬁrmed that>90%of
the clones encoded complete scFvs.
Virus propagation, titration and detection
To generate virus stocks, 50–70% conﬂuent HEK-293T cells
[human kidney epithelia; originally referred to as293tsA1609-
neo (23)] grown in T175 ﬂasks were transfected with 28 mg
of plasmid DNA using Lipofectamine
TM (Life Technologies).
Two days after transfection, virus-containing supernatants
were ﬁltered through a 0.45 mm sterile ﬁlter and aliquots were
stored at  80 C. Further harvests were possible after cultiva-
tion in serum-free DMEM overnight.
Infectious particles released from NIH-3T3 (mouse ﬁbro-
blasts; ATCC CRL-1658) or HEK-293T cells were quantiﬁed
by immunostaining using the goat anti RLV-p30 serum (Qual-
ity Biotech), as described previously (18). RT activity was
determined using the C-type-RT Activity Assay (Cavidi
Tech) in accordance with the manufacturer’s instructions.
Binding-infection and particle binding assay
Murine EHS-derived laminin-1 (BD Bioscience), collagen IV
(10 mg/ml; BD Bioscience) or milk powder [3% in phosphate-
buffered saline (PBS), 0.45 mm sterile ﬁltrated] were coated
onto a 24-well cell culture plate overnight at 4 C. Next day,
antigen-containing wells were blocked using 3% milk powder
in PBS for 1 h at room temperature. After washing with
PBS, infectious viral particles were added and incubated for
3 h at 4 C. After washing with ice-cold PBS, NIH-3T3 cells
(4 · 10
5 per well) were added and incubated for 24 h at 37 C
in an atmosphere of 5% CO2. The number of infected cells was
quantiﬁed by immunostaining using the goat anti RLV-p30
serum (Quality Biotech), as described previously (18).
For the virus particle binding assay, serial dilutions of scFv
viruses were incubated with laminin-1 (10 mg/ml) coated
96-well cell culture plates or enzyme-linked immunosorbent
assay (ELISA) plates for 3 h at 4 C. After washing with ice-
cold PBS, bound viral particles were lysed andRT activitywas
determined using the C-type-RT Activity Assay (Cavidi Tech)
in accordance with the manufacturer’s instructions. Binding
curves were calculated by plotting the input RT activity
against the laminin-bound RT activity.
Selection of the virus library and fingerprint
analysis
For selection of the scFv virus library, one well of a 6-well
dish was coated with murine laminin-1 (10 mg/ml). On the
next day, 6 · 10
6 i.u. (infectious units) of the scFv library
(3.7 · 10
5 i.u./ml) was added for 3 h at 4 C. After washing
with ice-cold PBS, 2.5 · 10
6 NIH-3T3 cells were added and
cultivated overnight at 37 C in an atmosphere of 5% CO2.
CellswerethentransferredontoaT25cellcultureﬂaskandthe
cell culture supernatant was harvested 48 h later and stored at
 80 C till further analysis or was directly used for a next
round of selection. The stringency was increased by two
and three washing steps at the second and the third round
of the selection using ice-cold PBS followed by rigorous shak-
ing for 10 min at 4 C. After selection, virus was harvested
from the cell culture supernatant by ultracentrifugation in an
SW41 rotor (Beckman) at 30000 r.p.m. for 1 h at 4 C and
RNA was puriﬁed using the QIAamp Viral RNA Mini kit
(Qiagen) followed by treatment with DNase I (Promega).
For cloning and sequence analysis, the scFv-coding region
of the viral RNA was reverse transcribed into cDNA (pri-
mer EMoSeq, 50-CGTCTCCCGATCTCCATTGGTTAC-30),
which was then ampliﬁed by PCR using primers CB6
(50-CCCCTAATCCCCTTAATTCTTC-30) and EMoSeq. The
PCR fragments were subcloned and plasmid from single bac-
terial clones was sequenced using the standard primers SP6
and T7. For the ﬁngerprint analysis, the scFv-coding region
was ampliﬁed by colony-PCR using primers CB6 and EMo-
Seq, and the PCR fragments were digested with BstNI (NEB).
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Virus particles were harvested into serum-free medium and
then concentrated by ultracentrifugation in an SW41 rotor
(Beckman) at 30000 r.p.m. for 1 h at 4 C. Virus collected
from 11 ml supernatant was then suspended in 100 mlo f
ice-cold PBS, separated by electrophoresis on a 10% SDS–
polyacrylamide gel, and electrotransferred onto a nitrocel-
lulose membrane (Hybond
TM ECL; Amersham). The
membranes were probed with the anti RLV-gp70 or anti
RLV-p30 goat antisera (Quality Biotech) and incubated
with horseradish peroxidase (HRP)-conjugated rabbit anti-
goat antibodies (DAKO). Protein bands were visualized
using ECL (Pierce).
Expression of scFv and specificity ELISA
HEK-293T cells were transiently transfected with pCR3.1,
pCR3.1-L36, pCR3.1-L6 or pCR3.1-L28 plasmid using Lipo-
fectamine (Life Technologies). Supernatant was collected at
48 h and 20 ml was analysed for scFv expression by western
blotting using anti-myc monoclonal antibody (mAb) and
ELISA as described previously (22). Brieﬂy, 96-well
Maxisorp1 plates were coated with laminin-1 (10 mg/ml) in
PBS overnight at 4 C. Cell-free supernatants from transfected
cells were added for 1 h at room temperature and bound
scFv was detected with the anti-myc-HRP antibody (Life
Technologies).
RESULTS
Establishing the selection system
A key issue for setting up an effective selection system for
retroviral scFv display libraries is the recovery of virions
bound to the cognate antigen. We expected that virus particles
displaying the scFv via a ﬂexible linker peptide will be able
to attach to and then enter into the permissive cells while
being speciﬁcally bound to an antigen of choice. To verify this
hypothesis andtoset up a system forthe selectionofscFv from
retroviral display libraries, we chose murine laminin-1 as an
antigen and the scFv L36 as a model system (20). Three dif-
ferent types of viruses all based on the ecotropic Moloney
MLV strain (MoMLV) were used in this study. Starting
from the plasmid pE-XMo, which encodes the complete
MoMLV genome modiﬁed with an epidermal growth factor
(EGF) coding SﬁI/NotI cassette inserted between the 30 codon
of the signal peptide and the 50 codon of the SU domain,
viruses displaying L36 (L36-XMo) or the unrelated scFv
7A5 (21) (7A5-XMo) were generated (Figure 1). All these
viruses were then assayed for their ability to bind to
laminin-1 and various control antigens and for the subsequent
infection of NIH-3T3 cells being overlaid onto the virus–
antigen complex (‘binding-infection assay’).
To allow binding of viral particles, cell culture plates were
left either uncoated or coated with laminin-1, collagen or milk
powder. Subsequently, equivalent amounts of particles of each
virus type were added and allowed to bind for 3 h at 4 C. After
stringent washing, NIH-3T3 cells were added. Infected cells
were determined after 24 h by immunostaining of the viral
capsid protein p30. In contrast to the 7A5-XMo and E-XMo
viruses, the L36-XMo virus was able to bind to laminin-1 and
to infect NIH-3T3 cells (Table 1 and Figure 2A). Interestingly,
>60% of the input infectious particles of L36-XMo had been
retained on the antigen and infected the overlaid NIH-3T3
cells (Table 1). In addition, all the viruses including the L36
virus hardly bound to collagen, plastic and milk powder
Figure 1. Schematic representations of the retrovirus constructs and the
selection procedure. (A) All constructs contain the complete genome of the
MoMLVbeingcomprisedofthegag, poland envgenes.ASfiI/NotIcassetteis
inserted in the env gene between the 30 codon of the signal peptide (SP) and
the 50 codon of the SU domain. Polypeptides inserted into this cassette will
be displayed on the viral Env protein via a factor Xa cleavage site (Xa). (B)
Selection procedure for retroviral scFv libraries. The virus library is released
fromHEK-293TcellstransfectedwithpscFv-XMo.Thevirusparticlesarethen
incubated with laminin-1 coated cell culture plates to allow binding. After
binding and washing NIH-3T3 cells are added for infection. The infected cells
are then cultivated to produce virus particles for the next round of selection.
Table 1. Percentage of virus
a recovered upon binding to different antigens
Virus Antigen
Laminin Collagen Plastic Milk powder
MoMLV (%) 0.1 0.28 0.3 0.52
E-XMo (%) 0.04 0 0 0
7A5-XMo (%) 0.02 0.04 0 0
L36-XMo (%) >60 0.02 0.06 0
a5000 i.u. applied.
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antigen-bound virus by the addition of permissive cells is
highly efﬁcient and, therefore, suitable for the selection of
retroviral scFv libraries.
Next, we determined the minimal amount of laminin-
binding virus that can be recovered by this approach. For
this purpose, L36-XMo and 7A5-XMo particles were mixed
in different ratios from 1:1 to 1:10
 5 starting with 5 mU RT
activity, which corresponds to  2.5 · 10
7 virus particles each
(24).After binding and infection,viral RNA from supernatants
of the infected cells was isolated and ampliﬁed using
RT–PCR. To distinguish between both virus types, fragments
were digested with the restriction enzyme ClaI (Figure 2B,
lanes 1–14). Detectable signals of the scFv L36 after binding
and infection were found up to the 10
 4 dilution (Figure 2B,
lanes 9–13) corresponding to  2500 laminin-speciﬁc viral
particles among 2.5 · 107 non-speciﬁc particles. Given that
in stocks of wild-type MoMLV only  1% of the particles are
infectious, a few single antigen-bound infectious virus parti-
cles can obviously be recovered by this approach.
Selection of a retroviral scFv library on laminin-1
To generate a retroviral scFv library, we used the phage
population that was recovered after a ﬁrst selection cycle of
the human synthetic scFv phage display library Grifﬁn.1 for
binding to laminin-1 (5,20). In total, 4 · 10
3 bacterial clones
derived from infection with the selected phage particles were
pooled and used for preparationof the pHEN-2 plasmidlibrary
encoding the single round selected scFv repertoire. The
retroviral plasmid library pscFv-XMo was generated by sub-
stituting the SﬁI/NotI cassette of pE-XMo (Figure 1A) for
the corresponding cassette removed from the pHEN-2
plasmid library. The resulting plasmid library pscFv-XMo
was puriﬁed from a total of 2.3 · 10
4 bacterial clones. The
virus library was then produced on HEK-293T cells, which
are negative for the MoMLV receptor and thereby excluding
any bias in the virus library through virus propagation. Super-
natants harvested 48 h after transfection with pscFv-XMo
contained 6 · 10
6 i.u.
For selection, laminin-1 was coated on 6-well cell culture
plates. On the next day, the plate was blocked with milk
powder and incubated with 1.5 · 10
5 i.u. of the scFv-XMo
library at 4 C to allow binding. After binding, two washing
steps were performed to remove unbound viral particles. Then,
NIH-3T3 cells were added and incubated for 24 h to allow
infection. The cells were then detached and transferred
onto cell culture ﬂasks to allow virus propagation for 48 h
(Figure 1B). Two additional rounds of laminin binding, infec-
tion and virus propagation were performed. With each round
the stringency of selection was increased by additional wash-
ing steps. The propagation of virus was monitored by deter-
mining infectious particles after each round of selection as
well as by RT–PCR on genomic RNA puriﬁed from viral
particles harvested from the cell culture supernatant. In addi-
tion, speciﬁc PCR fragments for the scFv-coding region were
recovered after each selection round (data not shown).
To follow the selection on the molecular level, we per-
formed ﬁngerprint assays of the scFv-coding sequences isol-
ated from the virus library before and after the third round
selection (Figure 3). The scFv-coding sequences from 50 inde-
pendent randomly picked bacterial clones were ampliﬁed by
colony PCR and digested with the high-frequency cutting
restriction enzyme BstNI. Before selection highly diverse
restriction patterns were obtained, none of which occurred
more than twice (Figure 3A). After selection in contrast,
distinct patterns occurring at high frequency were observed
(Figure 3B). The most prominent clones L9, L28 and L6
appeared with frequencies of  32, 14 and 8%, respectively.
Thus, the selection process resulted in a strong enrichment of
individual viruses displaying speciﬁc antibody fragments.
To determine the laminin-binding activity of the virus
population before and after selection, equal amounts of
virus particles were incubated with immobilized laminin-1.
After binding and washing, the number of bound virus parti-
cles was determined by RT activity. Figure 4A shows that low
but signiﬁcant laminin-binding activity was detectable in the
virus library before selection. After the selection procedure,
however, the laminin-binding activity of the virus population
increased by almost 10-fold. Thus, particles displaying anti-
bodies speciﬁc for laminin-1 must have been enriched during
selection.
Figure 2. Laminin-bound retroviruses can be recovered. (A) NIH-3T3 cells
were added to immobilized laminin-1 incubated with 2.5 · 10
6 particles of
the 7A5-XMo (left panel) or the L36-XMo virus (right panel) after removal
of unbound particles. Infected cells (appearing in red colour) were detected
by immunostaining using specific antiserum for the viral capsid protein.
(B) Recovery efficiency of the L36-XMo. Approximately 2.5 · 10
7 7A5-
XMo virus particles were spiked with decreasing amounts (10-fold dilutions)
of L36-XMo virus particles. The relative amounts of both viruses were deter-
mined upon ClaI digestion of RT–PCR fragments generated on viral genomic
RNA before (Input, lanes 3–8) and after laminin binding and infection of
NIH-3T3 cells (Output, lanes 9–14) to laminin-1. Each of the lanes 3–8 and
9–14 corresponds to 10-fold dilutions of L36-XMo. The ClaI-digested frag-
ments derived from PCR using plasmids p7A5-XMo and pL36-XMo as tem-
plate served as controls, respectively (lanes 1 and 2).
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To characterize the selected scFvs, we cloned and sequenced
the three most prominent scFvs, such as L9, L28 and L6. The
CDR3 regions of all three scFvs differed completely from
those of L36. Only the VL CDR3 of L28 was related to
that of L36 (Table 2). We then reconstituted virus particles
displaying the three selected scFvs, and compared their
laminin-binding activitytothatoftheL36-XMovirus,respect-
ively. Serial dilutions of monoclonal virus populations were
incubated with immobilized laminin-1. All the reconstituted
viruses bound laminin at least as efﬁciently as the virus popu-
lation after selection. Clones L28-XMo and L6-XMo were up
to 2.5-fold more active than the pool of viruses after selection
and also slightly more active than the L36-XMo virus
(Figure 4B).
Next, we addressed the question if basic viral properties had
changed due to the selection process. First, we determined the
infectivity rates of the viruses L28-XMo, L6-XMo and L36-
XMo when being bound to laminin-1. As all the three viruses
were similar in their laminin-binding activities, subtle differ-
ences in this assay must be due to differences in the viral cell
entry events. Equivalent particle numbers were added to the
laminin-1 coated plates. After binding, NIH-3T3 cells were
added and the number of infected cells was determined. As
shown in Figure 5A, the L6- and L36-XMo viruses showed
very similar infectivity rates, while the increase in the ratio of
infectious among non-infectious particles was  2-fold for the
L28-XMo virus.
The increased infectivity rate of the L28-XMo virus could
be due to increased amounts of Env protein being incorpor-
ated into the viral particles. To explore this, we performed
western-blot analysis to determine the relative amounts of the
scFv-SU proteins and the capsid protein p30. Both selected
viruses showed very similar Env protein incorporation levels,
which were slightly above that of the L36-XMo virus
(Figure 5B).
Finally, we determined the expression and binding activities
oftheretrovirusselectedanti-lamininscFvs whenexpressedas
scFv alone in the absence of the viral context. For this purpose,
the antibody genes (L6, L28 and L36) were cloned into the
mammalian expression vector pCR3.1 (4). Transfection of
HEK-293T cells with plasmids pCR3.1-L6, pCR3.1-L28 or
Figure 3. Fingerprint analysis of the selected scFvs.RT–PCRfragments derivedfrom genomic viral RNA representingthe scFv fragmentcoding sequences before
(A) and after three rounds of selection (B) were cloned into bacteria. Colony-PCR fragments from 50 randomly picked bacterial clones were restricted with BstNI,
respectively. Similar restriction patterns were grouped and the patterns of the most prominent clones L9, L28 and L6 are indicated.
Figure 4. Laminin-1-binding activity of virus pools and selected scFv viruses.
(A)Analiquotof130mURTactivityoftheunselected(input)andtheselected
(output) virus populations were incubated with laminin-1 or milk powder
coated ELISA plates. After washing, RT activities of the retained virus
particles were quantified, respectively. (B) Different amounts of RT activity
(input) of the unselected (orange line) and the selected (red line) virus popula-
tions as well as of the reconstituted L6-XMo (closed triangles, blue line),
L9-XMo (closed diamonds, blue line), L28-XMo (closed squares, blue line)
andL36-XMoviruses(closedcircles,greyline)wereincubatedwithlaminin-1
coatedELISAplates.Afterwashing,RTactivitiesoftheretainedvirusparticles
were quantified, respectively (output). Average values of three independent
experiments are given.
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signiﬁcant levels. Upon incubation of the cell culture super-
natant with immobilized laminin, speciﬁc binding activity
was detectable for both retrovirus selected scFv molecules
(Figure 6A). In fact, the L28 and especially the L6 scFvs
were signiﬁcantly more efﬁcient in laminin binding than the
phage selected L36 scFv (Figure 6A). These binding differ-
ences could be due to either differences in the afﬁnity of
binding or differences in the antibody expression level.
Although further experiments are necessary to determine anti-
body afﬁnities, our data demonstrate that the retrovirus selec-
ted scFvs were expressed at higher levels than the phage
selected scFv, especially the L28 clone, which was about four
times more efﬁciently expressed than the phage-derived L36
clone (Figure 6B).
DISCUSSION
The data presented here demonstrate that scFv libraries
displayed on the surface of the retrovirus MoMLV can be
generated and selected to obtain functional scFvs for a
given antigen. While other display platforms, such as phage
and yeast (3,5,25), are well established for the selection of
scFvs the use of animal viruses infectious for mammalian cells
has not yet been described.
Table 2. CDR3 sequences of retrovirus and phage
a selected scFvs
ScFv VH CDR3 VL CDR3
L6 (retrovirus) GDIRLRDP NSRDSSGIQNV
L9 (retrovirus) GEFSLMLEA NSRDSSGNHV
L28 (retrovirus) VELDSFDY AAWDDSLGLI
L32 (phage) SLFPLFD AAWDDSLAFV
L34 (phage) TALTAQL AAWDDSLLSFV
L36 (phage) YSAMADY AAWDDSLPAIV
aMostefficientlaminin-1-bindingscFvsobtainedafterthreecyclesofselection
of the Griffin-1 library (4).
Figure 5. Characterization of the selected scFv-displaying viruses. (A) Infec-
tion rates of the selected viruses after bindingto laminin-1.An aliquotof 1 mU
of RT activity of the indicated viruses, respectively, was incubated with
laminin-1 coated cell culture plates. After washing, NIH-3T3 cells were added
and the number of infected cells was quantified 24 h post-infection by immu-
nostaining using the MLV capsid-specific antiserum. The average ratio of the
number of infected cells and the input RT activity, based on three independent
experiments, is provided. (B) Env protein incorporation into viral particles.
HEK-293T cells were transfected with plasmids, pL6-XMo (lane 5), pL28-
XMo (lane 4) and pL36-XMo (lane 3), respectively, or left untransfected
(lane 2). At day two after transfection, virus particles released from the cells
were separated on a 10% SDS–polyacrylamide gel. MoMLV wild-type virus
was loaded as a molecular weight marker control for the viral proteins.
Immunoblotting was performed using SU and capsid protein-specific antisera.
Figure 6. Functional characterization of scFv antibody molecules produced
by human cells. (A) Secretion of scFvs into the cell culture supernatant by
HEK-293T cells transiently transfected with plasmid pCR3.1, pCR3.1-L36,
pCR3.1-L6 or pCR3.1-L28. Antibody functionality was demonstrated by
ELISA against plastic immobilized BSA and laminin-1, respectively. Bound
scFv was detected with an anti-myc mAb. (B) Western-blot analysis of scFv
secreted into the cell culture supernatant by pCR3.1 (lane 2), pCR3.1-L36
(lane 3), pCR3.1-L6 (lane 4) or pCR3.1-L28 (lane 5) transfected HEK-293T
cells, respectively. An aliquot of 20 ml of supernatant of each transfectant was
loaded in each lane. An aliquot of 1 mg and 500 ng of recombinant L36 scFv
antibody purifiedfrom bacterialculture supernatant were loadedin lanes 1 and
6, respectively. Immunoblotting was performed using an anti-myc mAb.
Intensity of individual bands was evaluated by PCBas software (Raytest,
Germany).Thevalueswerenormalizedtotheintensityofcontrolandexpressed
underneath the respective blot lane.
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display. While naked viruses, e.g. adenovirus, only tolerate
insertions of small peptides into their capsid proteins, large
polypeptides can be displayed on the surface of retroviruses
without compromising viral infectivity, also including heavily
glycosylated proteins, such as the prion protein (26). There-
fore, it was possible to establish a replication competent
library system which, in contrast to conventional phagemid-
based scFv libraries, is independent from helper virus. Espe-
cially when replication competent display platforms are being
used, the possibility that other parameters than antigen binding
drive the selection process is a concern. However, basic viral
properties, such as Env protein incorporation and infectivity,
did not change considerably during our selection procedure.
Instead, laminin-1-binding activities and expression levels
of the scFv molecules improved. Most importantly, this was
also the case when the selected scFvs were analysed as soluble
molecules in the absence of virus. Expression of the selected
scFvs in HEK-293T resulted in considerably large amounts of
 25 mg/l that are even above the range obtained upon expres-
sion in yeast (1–10 mg/l) (25). We, therefore, conclude that
antigen binding and expression were indeed the main driv-
ing forces of selection. The improved binding activity of the
soluble scFvs also suggests that the multivalent nature of scFv
expressed on the surface of retrovirus particles where
 50–100 Env molecules exist did not reduce the afﬁnity of
scFvs selected from retroviral libraries. Moreover, the applica-
tion of a replication competent display system offers, due to its
high mutation and recombination frequency, an additional
level of scFv diversiﬁcation.
An important observation while setting up the retrovirus-
basedselectionsystemwastheunimpairedinfectionefﬁciency
of laminin-bound virus particles being virtually as high as that
of free virus. This high degree of ﬂexibility in the cell entry
events involving receptor attachment and membrane fusion
seems to be a unique property of retroviruses but is not limited
to the use of laminin as antigen. The immobilization of ret-
rovirus particles to other cell adhesion molecules, transmem-
brane receptors or antibodies similarly resulted in unimpaired
or even increased infectivity if compared with free virus
(19,27). For the library selection process, scFv displaying
retroviral particles bound to their cognate antigen can, there-
fore, easily be rescued by adding permissive mammalian cells.
Thus, there is no need for elution procedures so that high-
afﬁnity antibodies cannot get lost during selection. Moreover,
this concept may also be easily applied to the use of living
human cells as antigen source if ecotropic retroviruses as
shown here are used as display platform. Then, scFvs directed
against transmembrane cell surface proteins that are difﬁcult
to purify in a native conformation can be selected.
Although the repertoires that can be covered with retroviral
libraries, at least in their current stage of development, are
clearly below that of phage libraries, enrichment efﬁciencies
as well as sensitivity were well within the range of phage
systems. Our data show that a single selection round enriched
at least 10
3-fold and that as few as 25 antigen bound infectious
particles were sufﬁcient to go into the next selection round.
Retrovirus display libraries covering complexities of 10
6–10
8
can be generated (18,19). This level of complexity is sufﬁcient
for the screening of the scFv repertoire present in immunized
donors. Alternatively, single round selected pools of phage
particles as demonstrated here can serve as ideal starting
point for the selection in retroviral systems. In this respect,
it is remarkable that the scFvs selected from the retroviral
library clearly differed in their CDR sequences from scFvs
that were obtained after two further phage selection rounds
(Table 2). Most probably, these differences reﬂect the adapta-
tion of molecular parameters, such as codon usage, polypep-
tide folding and resistance to inactivation by mammalian cell
proteases. Translational problems that occur when molecules
selected in the context of phage have to be transferred onto
mammalian expression systems to exert their therapeutic
potential can be avoided. Thus, antibodies selected in the
contextofretroviruseswill, forexample, improvetheir expres-
sion from retroviral vectors or their use as anti-tumoral
targeting domains in gene therapy applications.
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